By Lucía Tedesco via El Planteo
Uruguay’s National Party has filed a bill to legalize psychedelics. Led by Sen. Juan Sartori, the proposal seeks to provide access to these substances which have been proven to be an effective treatment for numerous mental health conditions.
Sartori’s bill would make access to psychoactive plants legal if prescribed by a physician. The senator also seeks to decriminalize the use, distribution and commercialization of psychedelics for scientific or medical-therapeutic uses, reported El Pais Uruguay.
If approved, psychedelics could be consumed under a psychiatrist’s supervision to guarantee safe use.
“The unregulated use and the commercial sale of substances that without a medical follow-up may imply health risks will be avoided,” Sartori said.
The natural entheogenic substances the new bill would legalize include psilocybin, methylenedioxymethamphetamine, ibogaine, dimethyltryptamine (DMT), mescaline, and psilocin. Activities such as cultivation, distribution, possession and use, not sale, would be part of the new legal framework.
Who Is Juan Sartori?
Sartori, a member of the center-right national party, has served as a senator since February 2020. A businessman, Sartori has invested in various industries including energy, real estate and cannabis.
Several years ago, Sartori founded an investment fund that appears to share similar interests as the psychedelics industry. Sartori recently said on Twitter that he seeks to “allow the medical use of natural psychoactive substances in treatments like depression and anxiety.”
- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Benzinga’s Psychedelics Capital Conference
April 13th at the Fontainebleau Miami Beach Hotel will be THE place to set up deals, raise money, meet investors and key partners, and learn from the industry’s greatest.
Get your tickets now and don’t miss out!
Más contenido de El Planteo:
- Ibogaína: Qué Es el Psicodélico Disociativo que Podría Tratar Adicciones
- ¿Cómo se Hace la Psilocibina? Todo lo que Hay que Saber
- Qué es el Peyote: Todo sobre el Cactus de la Mescalina
Photo by engin akyurt on Unsplash
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!